What Are the Main Signals for Medtronic (NYSE:MDT) Right Now?

  • A company announcement confirmed that Medtronic (NYSE:MDT) on October 7, 2026 a final exchange ratio of 4.5939 MiniMed shares per Medtronic share, which equals the upper limit, so the cap is in effect.
  • The split-off offer covers up to 225,361,295 MiniMed (NASDAQ:MMED) shares, or 80.1% of the company, and is because of expire at midnight New York time on October 9, 2026 unless extended.
  • Medtronic holds 252,813,348 MiniMed shares, about 90%, after the March 2026 IPO at USD 20; MiniMed closed at USD 19.14 on October 7 in published market data.
  • If the offer is oversubscribed, Medtronic (NYSE:MDT) intends to exchange its remaining 27,452,053 MiniMed shares too, and tendered Medtronic shares would be prorated, with accepted shares cancelled.

What Could Medtronic Announced on October 7 Mean for Medtronic (NYSE:MDT)?

In a release at 5:31 p.m. ET on October 7, 2026, Medtronic (NYSE:MDT) said the final exchange ratio is 4.5939 MiniMed shares for each Medtronic ordinary share accepted. The company indicated that that the calculated ratio would have exceeded the upper limit of 4.5939, so the limit applies. Medtronic indicated that it would accept about 49.1 million of its own shares if it keeps the base offer, or about 55.0 million if it uses the full remaining stake. The offer expires at the end of October 9, 2026, at 12:00 midnight New York City time, unless extended or terminated. Tendered shares can be withdrawn until expiry. Dealer managers are Goldman Sachs and BofA Securities.

How Could the Ratio and the Cap Work Affect Medtronic (NYSE:MDT)?

The terms were set when the offer launched on September 14, 2026. Although MiniMed shares are valued at 93% of their average, a 7% discount, Medtronic shares are valued at 100% of the Average Daily Volume weighted price over October 5, 6 and 7. The limit of 4.5939 binds when MiniMed trades low relative to Medtronic. Without a limit, holders were projected to receive about USD 107.53 of MiniMed stock for every USD 100 of Medtronic stock tendered. Simple arithmetic on one published number: 4.5939 shares at MiniMed's USD 19.14 close equals about USD 87.93 of MiniMed stock per Medtronic share, so the usual discount cushion is thinner than first advertised.

What Could Still Pressure Medtronic (NYSE:MDT), and What Comes Next?

The offer needs at least 112,680,647 MiniMed shares issued, about half the base amount, and a Skadden opinion that the exchange is generally tax-free under Section 355, apart from cash for fractional shares. Only U.S. holders may take part, and odd-lot holders under 100 shares who tender everything are not prorated. MiniMed slipped 17.8% over the past month, per published market data. If the offer is undersubscribed, Medtronic would keep roughly 9.76% of MiniMed and plan a later spin-off, split-off or debt-for-equity exchange. Watch the extension notice, final tender figures and the preliminary proration factor, due the Business day after expiry. Medtronic's USD 0.72 dividend is payable October 16, 2026.

Where Does Medtronic (NYSE:MDT) Stand After the Latest Update?

Medtronic (NYSE:MDT) fixed the ratio at the 4.5939 cap on October 7, 2026 because the formula result exceeded that limit, which happens when MiniMed trades weakly against Medtronic. The company has not reported tender figures. The offer remains open until midnight on October 9 unless extended, and the outcome depends on how many shareholders judge roughly USD 87.93 of MiniMed stock per share, at the October 7 close, worth exchanging. Figures here are from the company release and published market data, not forecasts or advice.

What Should Investors Know Next About Medtronic (NYSE:MDT)?